Harvey Partners’s Rentokil RTO Stock Holding History
Bought
Maintained
Sold
Other funds holding RTO
GCM
RRAM
SCM
SL
Harvey Partners's RTO Position: Q1 2026 in Review
Harvey Partners increased its Rentokil (RTO) stake by 10% in Q1 2026, buying an estimated $2.81M and bringing the position to 975,500 shares worth $30.7M. The position accounts for 2.44% of the portfolio, ranked #19.
Harvey Partners first reported a position in RTO in Q4 2022 and has held it in 14 quarters since. The position peaked at $41.2M in Q4 2024. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.
- Harvey Partners held 975,500 shares of Rentokil worth $30.7M as of Q1 2026.
- Harvey Partners bought 89,331 Rentokil shares in Q1 2026, an estimated $2.81M.
- Rentokil made up 2.44% of Harvey Partners's portfolio in Q1 2026, its #19 holding.
- Harvey Partners first reported a position in Rentokil in Q4 2022 and has held it in 14 quarters since.
- Harvey Partners's Rentokil position peaked at $41.2M in Q4 2024.
- 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.
Based on Harvey Partners's 13F filing for Q1 2026, filed 15 May 2026.